North America’s BEST Small Cap Stock Ideas
Hemispherx Biopharma (HEB – $0.62) announced that it received a complete response letter from the U.S. Food and Drug Administration (“FDA”) which describes specific additional recommendations related to the Ampligen NDA. In accordance with its 2008 “Complete Response” procedure, the FDA reviewers determined that they cannot approve the application in its present form and provided specific recommendations to address the […]
Read more
Global Greensteam LLC, a subsidiary of Global Green Solutions Inc. (GGRN – $0.14), announced on Tuesday it has begun construction of its demonstration unit at Aera Energy’s Belridge oil field near Bakersfield, California. Additionally, Aera has made a significant financial contribution to construct the demonstration unit. Because this is such important news, we invited Mr. Craig Harting, COO of Global […]
Read moreWe usually don’t send a newsletter just to let you know that a press release has been issued by a Company that we follow. However, we believe today’s press release by Global Green Solutions (GGRN – $0.13) is so important it justifies a special newsletter. Global Greensteam LLC, a subsidiary of Global Green Solutions Inc., has begun construction of its […]
Read moreChina Jo-Jo Drugstores, Inc. (CJJD – $2.65) operates 22 retail pharmacy stores in China offering both western and traditional Chinese medicine. Additionally, the Company provides access to licensed physicians providing consultations and/or outpatient services. China Jo-Jo Drugstores was listed on the OTCBB in September of 2009 and reported its second quarter results a couple of weeks ago. Net sales for […]
Read moreIn FY 2009, Acme United’s (ACU – $9.45) sales will decline for the first time in many years due to a general drop in demand and due to inventory reductions with its customers. In our third quarter update report we not only explain why it’s safe to assume that revenues and earnings will increase again once the economy turns around, […]
Read moreDAC Technologies (DAAT – $0.79) announced third quarter results for the period ending September 30, 2009, on Monday. Revenues for the third quarter were down 21% compared with the third quarter in 2008 because the Company stopped selling low margin products and concentrated on higher margin items. That was reflected in the earnings which were only down 12% compared to […]
Read moreOn Monday, DAC Technologies (DAAT – $0.73) announced third quarter results for the period ending September 30, 2009. So we thought this was a good time to conduct an interview with Mr. David Collins, the Company’s president and CEO, to give you a more in depth look into DAC’s current condition and future plans. To listen to the interview, click […]
Read moreNow that we finally started to see some light at the end of the New Drug Application (NDA) tunnel for Hemispherx Biopharma (HEB – $1.00) , they seem to have sailed into murky legal waters. Since its November 2 press release, in which the Company gave an update on its NDA for Ampligen, several law firms have filed a class […]
Read moreOn Thursday, Acme United Corporation (ACU – $8.40) announced that net sales for the third quarter ended September 30, 2009 were $15.3 million compared to $19.2 million in the comparable period of 2008, a decrease of 20% (19% local currency). Contributing to the decline was an unexpected order of approximately $1.2 million from a major retailer in the third quarter […]
Read moreThe five stocks that we recommended in 2009 have done very well so far. At today’s closing prices, our five recommendations: Hemispherx Biopharma (HEB), Orsus Xelent (ORS), Boots & Coots (WEL), Acme United (ACU) and Global Green Solutions (GGRN) are up between 30 and 370 percent, or +127% on average. Obviously, it’s impossible to predict if our following recommendations will […]
Read more